Triclinium Clinical Trial Project Management   Report issue

For profit Phase 2
Founded: Johannesburg South Africa (2000)

Organization Overview

First Clinical Trial
2009
NCT01135251
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Triclinium Clinical Development Middle East and North Africa | Triclinium Clinical Development (Pty) Ltd | Triclinium Clinical Trial Project Management (Pty) Ltd. | Triclinium clinical trial project managment LTD | Triclinium Johannesburg, RSA (Monitoring and Overall Management of the study) | Triclinium Johannesburg, South Africa

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Malaria (Phase 2)

Peripheral Nervous System Diseases (Phase 2)

Tuberculosis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 6
  • # of Trial APIs: 5